Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial

INTRODUCTION: This is a multicentre, open-label, single-arm clinical trial to evaluate the efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer. METHODS AND ANALYSIS: The trial will be performed at 4 university hospitals and 14 city hospitals in Japan....

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Hideaki, Kakei, Yasumasa, Nakano, Yuzo, Terakawa, Tomoaki, Miyakoda, Keiko, Harada, Kenichi, Fujisawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069569/
https://www.ncbi.nlm.nih.gov/pubmed/36990491
http://dx.doi.org/10.1136/bmjopen-2022-070173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069569/
https://www.ncbi.nlm.nih.gov/pubmed/36990491
http://dx.doi.org/10.1136/bmjopen-2022-070173

Ejemplares similares